Search research articles
Contact Us
Filters
Showing results (51-60 of 104) with videos related to
Page
of 11
Sort By:
Clinical Pharmacology and Therapeutics
|
June 5, 2020
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study
Päivi Hirvensalo, Aleksi Tornio, Terhi Launiainen, et al.
Anesthesia and Analgesia
|
November 12, 2020
Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers
Terhi J Lohela, Satu Poikola, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics
|
November 25, 2017
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans
Matti K Itkonen, Aleksi Tornio, Anne M Filppula, et al.
Clinical Pharmacology and Therapeutics
|
April 27, 2018
Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
Matti K Itkonen, Aleksi Tornio, Outi Lapatto-Reiniluoto, et al.
European Journal of Clinical Pharmacology
|
January 16, 2010
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone
Teijo I Saari, Juha Grönlund, Nora M Hagelberg, et al.
British Journal of Clinical Pharmacology
|
May 26, 2006
Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes
Mia Hedman, Marjatta Antikainen, Christer Holmberg, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2025
Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans
Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 1, 2024
In vitro assessment of inhibitory effects of kinase inhibitors on CYP2C9, 3A and 1A2: Prediction of drug-drug interaction risk with warfarin and direct oral anticoagulants
Shasha Jin, Marie-Noëlle Paludetto, Mika Kurkela, et al.
European Journal of Clinical Pharmacology
|
August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
Tuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 22, 2010
Grapefruit juice enhances the exposure to oral oxycodone
Tuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Page
of 11
Search research articles
Search
Showing results (51-60 of 104) with videos related to
Sort By:
Page
of 11
Clinical Pharmacology and Therapeutics
|
June 5, 2020
UGT1A3 and Sex Are Major Determinants of Telmisartan Pharmacokinetics-A Comprehensive Pharmacogenomic Study
Päivi Hirvensalo, Aleksi Tornio, Terhi Launiainen, et al.
Anesthesia and Analgesia
|
November 12, 2020
Rifampin Reduces the Plasma Concentrations of Oral and Intravenous Hydromorphone in Healthy Volunteers
Terhi J Lohela, Satu Poikola, Mikko Neuvonen, et al.
Clinical Pharmacology and Therapeutics
|
November 25, 2017
Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8-Mediated Metabolism of Montelukast in Humans
Matti K Itkonen, Aleksi Tornio, Anne M Filppula, et al.
Clinical Pharmacology and Therapeutics
|
April 27, 2018
Clopidogrel Increases Dasabuvir Exposure With or Without Ritonavir, and Ritonavir Inhibits the Bioactivation of Clopidogrel
Matti K Itkonen, Aleksi Tornio, Outi Lapatto-Reiniluoto, et al.
European Journal of Clinical Pharmacology
|
January 16, 2010
Effects of itraconazole on the pharmacokinetics and pharmacodynamics of intravenously and orally administered oxycodone
Teijo I Saari, Juha Grönlund, Nora M Hagelberg, et al.
British Journal of Clinical Pharmacology
|
May 26, 2006
Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms of the SLCO1B1 and ABCB1 genes
Mia Hedman, Marjatta Antikainen, Christer Holmberg, et al.
Clinical Pharmacology and Therapeutics
|
December 14, 2025
Repeated Intake of Grapefruit Juice Inhibits CYP2B6, CYP2C9, CYP2C19, and CYP3A4 while Lingonberry Powder Does Not Induce Major CYP Enzymes in Humans
Laura Aurinsalo, Outi Lapatto-Reiniluoto, Mika Kurkela, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences
|
September 1, 2024
In vitro assessment of inhibitory effects of kinase inhibitors on CYP2C9, 3A and 1A2: Prediction of drug-drug interaction risk with warfarin and direct oral anticoagulants
Shasha Jin, Marie-Noëlle Paludetto, Mika Kurkela, et al.
European Journal of Clinical Pharmacology
|
August 11, 2010
Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir
Tuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Basic & Clinical Pharmacology & Toxicology
|
April 22, 2010
Grapefruit juice enhances the exposure to oral oxycodone
Tuija H Nieminen, Nora M Hagelberg, Teijo I Saari, et al.
Page
of 11